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mean results obtained in the two groups were then com-
pared using Student’s t test.  Results: The balance of fl u-
ids calculated up to t 1  was 675  8 308 ml for group A and 
1,411  8 405 ml for group B (p  ! 0.01). The means of the 
recorded values that showed statistically signifi cant dif-
ferences were: mean percent concentration ratio (43.6  8 
8.4 vs. 84  8 16%; p  ! 0.05), concentration in the colonic 
segment (16.3  8 7.9 vs. 37.2  8 25.9 mg/ml; p  ! 0.05), 
urinary volume gathered up to t 1  (538  8 557 vs. 169  8 
104 ml; p  ! 0.05), hourly urinary volume up to t 1  (311.1 
 8 296 vs. 97.6  8 77.9 ml/h; p  ! 0.05), percent variation 
of resistance (95.1  8 5.1 vs. 89.7  8 8.6; p  ! 0.05). The 
other means did not show any signifi cant statistical dif-
ferences.  Conclusions: A higher tissue water level seems 
to facilitate the penetration of the antibiotic into the tis-
sue according to the pharmacokinetic characteristics of 
ceftizoxime: high amount of free drug (not bound to plas-
ma proteins) and high hydrosolubility. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 The effectiveness of perioperative surgical infection 
prophylaxis depends on the following pharmacological 
aspects of the antimicrobial agent used: (a) the optimal 
time for antibiotic administration which is at induction 
of anesthesia  [1] ; (b) the highest concentration that must 
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 Abstract 
 Aim of Study: To demonstrate that administration of fl u-
ids and the consequent improvement of fl uid balance 
during a surgical procedure can modify the tissue diffu-
sion of ceftizoxime.  Methods: Twenty-eight patients (30–
79 years) undergoing major abdominal surgery of the 
colon were administered ceftizoxime 30 mg/kg i.v. at in-
duction of anesthesia. A sample of arterial blood was 
taken before administration of the drug (t 0 ) and then 
again at the time of vascular occlusion of the colon seg-
ment to be removed (t 1 ). A sample of the segment of 
removed colon was taken. The patients were divided into 
two groups on the basis of the fl uid balance between t 0  
and t 1 : group A (n = 17) with a fl uid balance  ! 1,000 ml 
and group B (n = 11) with a fl uid balance  1 1,000 ml. The 
parameters evaluated in each group were: weight, height 
and age of the patients, serum and tissue antibiotic con-
centration, percent ratio of serum and tissue concentra-
tion, time elapsed between t 0  and t 1 , volume of adminis-
tered fl uids between t 0  and t 1 , diuresis and hourly 
diuresis between t 0  and t 1  and body fl uid distribution, 
obtained using a bioelectrical impedance analyzer. The 
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be obtained in the tissues where bacteria grow  [2] ; (c) the 
antibiotic serum concentration that must be higher than 
the minimal inhibitory concentration of the possible con-
taminating bacteria during an intervention  [3] . 
 Intraoperative fl uid therapy could interfere with these 
aspects by modifi ng body fl uid compartment distribu-
tion. In particular, fl uid balance, hemodilution, and in-
terstitial fl uid content  [4] may infl uence the tissue diffu-
sion of antimicrobial agents. 
 The aim of this study was to evaluate whether an in-
traoperative positive fl uid balance can modify the tissue 
diffusion of a cephalosporin (ceftizoxime) with a high 
amount of free drug (not bound to plasma proteins) and 
high hydrosolubility, administered for short-term surgi-
cal infection prophylaxis. 
 Patients and Methods 
 Thirty-fi ve consecutive ASA I-II patients undergoing major co-
lon surgery under general anesthesia, were admitted to the study. 
All the patients were informed about the goals of the study and 
gave their signed, written consent. All the patients were submitted 
to the same bowel preparation and were weighed immediately be-
fore the start of the intervention. The surgical procedures were 
performed by the same surgeon and via the same cutaneous xipho-
pubic incision with removal of a segment of colonic tissue. Seven 
patients requiring blood transfusions,  blood derivatives, vasoac-
tive drugs administered for hemodynamic instability or diuretics 
up to resection of the colon segment  were excluded from the 
study. 
 The anesthetic technique was the following: premedication with 
morphine (10 mg i.m.) followed by the induction of anesthesia with 
Fentanyl (1.5   g/kg), Propofol (2 mg/kg) and Atracurium (0.6 mg/
kg), Isofl urane MAC95 in O 2  and air, and continuous intravenous 
administration of Atracurium (0.4 mg/kg/h until reawakening). 
 As the administration of different volumes of fl uids can modify 
the clearance of the antibiotic, the protocols of fl uid infusion were 
the same during the period of the study; crystalloid solutions
(Ringer acetate) were given to all the patients at the dosage of
15 ml/kg/h during the fi rst hour and 12 ml/kg/h up to the end. 
 Ceftizoxime 30 mg/kg was administered over 10 min through a 
peripheral vein at induction of anesthesia. A 5-ml arterial blood 
sample was taken immediately before the induction of anesthesia 
(t 0 ) to obtain the baseline standard serum antibiotic concentration 
and the hematocrit values. A second 5-ml arterial blood sample was 
taken at the time of vascular occlusion of the colonic segment to be 
removed (t 1 ) to measure the serum antibiotic concentration and 
hematocrit. 
 A fragment of the removed segment of approximately 5  ! 1 cm 
was washed with saline, dried with sterile gauze and conserved in 
a test tube at –20  °  C. The tissues were weighed, diluted 1:  1 (wt/vol) 
in sterile normal saline (pH 6.3), homogenized with a Polytron PT 
10–35 homogenizer (Kinematica, Lucerne, Switzerland), and cen-
trifuged at low speed; the supernatant was used for the assay  [5] . 
 The concentration of the antibiotic in serum and tissues was 
determined in triplicate by a validated large-plate agar diffusion 
technique, according to Good Laboratory Practice (GLP) standards 
 [6, 7] . Ceftizoxime concentrations were determined using the An-
tibiotic Medium II (BBL) as the culture medium and  Escherichia 
coli  Sc 12,355 as the test organism, with a lower limit of sensitivity 
of 0.125 mg/l. Standard concentrations were prepared daily in 
pooled serum for blood samples and in normal saline for tissue 
specimens. The test organism was added by the surface layer tech-
nique. After homogeneous distribution of the culture, the excess 
liquid was removed with a pipette. The plates were incubated at 
37  °  C in air overnight. 
 Best-fi t standard curves were obtained by linear regression anal-
ysis. The linearity was log y = 0.102x – 1.8 for plasma samples and 
log y = 0.103x – 1.95 for tissues; the correlation coeffi cient was not 
less than 0.99. Intra-assay precision ranged from 4.5 to 9.8% for 
serum samples and from 1.3 to 7.4% for tissue samples. Inter-assay 
precision at a level of 1 mg/l ranged from 1.83 to 4.82% for serum 
and from 1.4 to 5.8% for tissues. 
 The ratio of serum antibiotic concentration at t 1  to tissue anti-
biotic concentration was calculated as percent ratio. The fl uid bal-
ance between t 0  and t 1  was obtained by calculating the difference 
between the volume of the administered fl uids and the intraopera-
tive losses due to fasting (2 ml/kg/h), perspiratio insensibilis (8 ml/
kg/h of surgery) and diuresis. A cutoff value of intraoperative fl uid 
balance was chosen (1,000 ml) to divide the patients into two groups 
on the basis of the intraoperative fl uid balance reported in other 
works  [8, 9] and the time between the induction of anesthesia and 
the time of vascular exclusion of the colonic segment to be removed 
previously measured (about 90 min): group A (n = 17) with in a 
fl uid balance between t 0  and t 1   ! 1,000 ml and group B (n = 11) with 
in a fl uid balance  1 1,000 ml. The mean weight, height and age were 
calculated in the two groups. To evaluate the effect of fl uid balance 
on tissue diffusion of the antibiotic, the following parameters were 
registered or calculated: tissue concentration of the antibiotic (mg/
ml); ratio of tissue to plasma concentration (%); diuresis between 
t 0  and t 1  (ml); hourly diuresis between t 0  and t 1  (ml/h), hematocrit 
between t 0  and t 1  (expressed as percentage), and time elapsed be-
tween t 0  and t 1  (min). 
 To evaluate the body compartment distribution of adminis-
tered fl uids, an impedance analyzer (BIA/STA TM  Akern S.r.l. Flor-
ence, Italy)  [10–12] was used to measure the variation of resistance 
between t 0  and t 1  (%), which expresses conductor opposition to the 
fl ow of alternate currents, and is inversely proportional to total 
body fl uids, and the variation in capacitive reactance between t 0  
and t 1  (%), which expresses condenser opposition to the fl ow of al-
ternating current, and is directly proportional to cellular mass. 
 Statistical analysis was performed using Student’s t test. A p 
value  ! 0.05 was considered signifi cant. 
 Results 
 Group A (n = 17) and group B (n = 11) were not sta-
tistically different in terms of age (respectively: 57.7  8 
12 vs. 54.7  8 14 years), weight (68.9  8 8.4 vs. 72.9  8 
9.1 kg) and height (165  8 9.9 vs. 168.2  8 6.6 cm). 
 Group A patients had a mean fl uid balance of 675  8 
308 ml, while group B had a higher mean fl uid balance: 
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1,411  8 405 ml (p  ! 0.05). Mean tissue concentration 
(16.3  8 7.9 of group A vs. 37.2  8 25.9 of group B, p  ! 
0.05), mean ratio of tissue to serum concentration (43.6 
 8 28.4% of group A vs. 84  8 16% of group B; p  ! 0.05), 
mean diuresis (538  8 557 ml of group A vs. 169  8 104 
ml of group B, p  ! 0.05), mean hourly diuresis (311.1  8 
296 ml/h of group A vs. 97.6  8 77.9 of group B, p  ! 0.05) 
and mean percent variation of the resistance (95.1  8 5.1 
of group A vs 89.7  8 8.6 of group B, p  ! 0.05) were sta-
tistically signifi cantly different in the two groups (p  ! 
0.05). The results are reported in table  1 . The linear cor-
relation between tissue concentration versus intraopera-
tive fl uid balance is shown in fi gure  1 . 
 Fig. 1. Linear correlation between tissue concentration of ceftizoxime and intraoperative fl uid balance in a series 







Fluid balance, ml 6758308 1,4118405 <0.05
Tissue /serum concentration, % 33.688.4 93.985.9 <0.05
Tissue concentration in the colonic
portion, mg/ml 16.387.9 37.2825.9 <0.05
Serum concentration, mg/ml 49.6824 40.1826.6 NS
Diuresis, ml 5388557 169.38104 <0.05
Hourly diuresis, ml/h 311.18296 97.6877.9 <0.05
Hematocrit variation, % 8387.3 81.3810.4 NS
Resistance variation, % 95.185.1 89.788.6 <0.05
Capacitive reactance variation, % 108.8821  106.9827 NS
Time elapsed between t0 and t1, min 79834 92822 NS
Statistics: Student’s t test; p < 0.05 was considered signifi cant.
 
 Table 1. Mean ( 8 standard deviation) of 
the values measured between t 0  (start of 
intervention) and t 1  (vascular exclusion 
 of the colonic segment to be removed) 
 in two groups of patients: group A: 
 fl uid balance <1,000 ml; group B: fl uid 
balance >1,000 ml 
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 Discussion and Conclusion 
 The ideal characteristics of short-term antimicrobial 
prophylaxis include: use of antibiotic with a narrow spec-
trum of activity that includes the main pathogens respon-
sible for postoperative infections, bactericidal effect, high 
therapeutic index, high tolerability, favorable kinetic pa-
rameters such as intravenous administration, long half-
life of elimination and good tissue penetration  [1] . 
 The tissue diffusion of the antibiotic mainly depends 
on the gradient existing between plasma and tissue con-
centrations  [13] . The gradient can be reduced if the anti-
biotic has a high percentage of protein binding: only the 
drug not bound to protein diffuses into tissue. 
 Anesthesia and surgical trauma can interact with tis-
sue diffusion of drugs: hemodilution and replacement of 
intraoperative blood loss can determine homeostatic 
modifi cations in body fl uid: general anesthesia and vaso-
active drugs can modify the vascular system  [14–16] . In 
addition, the depression of sympathetic tone observed at 
induction of anesthesia can cause previously adequate 
refi lling pressure to become insuffi cient  [17, 18] . There-
fore, it may be necessary to expand the circulating volume 
before or immediately after the induction of anesthesia 
and during the intervention  [19, 20] . 
 Finally, the vascular splanchnic capacity can suddenly 
increase when intra-abdominal pressure is rapidly re-
duced by a laparotomy  [21] . These physiological modifi -
cations, induced by anesthesia and surgery, require ad-
ministration of fl uid and a fl uid balance between the ad-
ministered fl uids and the intraoperative losses must be 
achieved. The imperceptible losses include the amount of 
fl uid that must be reinfused as a basal requirement
(2 ml/kg/h) to maintain equilibrium and that lost due to 
surgery, which depends on the type of surgery (minor: 
4 ml/kg/h, intermediate: 6 ml/kg/h, major: 8 ml/kg/h) 
 [22] . The fl uid balance must be calculated during surgery 
because fl uid overload may be responsible for the onset 
of interstitial edema that can lead to hypoxemia at the 
pulmonary level and cause prolonged postoperative in-
tensive care in patients with reduced cardiopulmonary 
capacity  [23] . Instead, hypovolemia may lead to oliguria 
which, in addition to the reduction in glomerular fi ltra-
tion caused by the anesthetics, reduces cardiac output 
(and thus oxygen transport), decreasing the ability to tol-
erate and adapt to signifi cant hematocrit and hemoglobin 
reduction  [24] . 
 The aim, therefore, is to re-establish the volume, which 
must be empirically evaluated by measuring the systemic 
arterial pressure, maintaining a value that can assure blood 
distribution to all the organs in a way that allows an ade-
quate supply (DO 2 ) and consumption (VO 2 ) of oxygen. 
 The effects of hemodilution on the administered drug 
concentration during anesthesia and on the diffusion of 
these drugs in the interstitium are not well understood. 
Antibiotic tissue distribution during the intraoperative 
period and its relationship with intraoperative fl uid bal-
ance has not been studied enough. 
 Ceftizoxime is a third-generation cephalosporin that, 
in recent years, has been widely used in the prophylaxis 
of postoperative infection for its particular effi cacy against 
Enterobacteriaceae involved in the infections occurring 
in ‘clean-contaminated’ surgery. It has, therefore, become 
an alternative prophylaxis in abdominal surgery. After a 
bolus administration, the pharmacokinetics of ceftizox-
ime are well suited for prophylaxis. The concentrations 
reached after intravenous bolus administration of 1 g are 
107–136 mg/l  [25] . The volume of distribution studied in 
healthy volunteers is 15–28 liters  [26] ; the elimination 
half-life is 1.1–2.2 h  [27] ; serum clearance is 110–200 ml/
min and renal clearance is 100–160 ml/min, just high 
enough to enable 70% of the drug to reach the urine with-
in 2 h of administration  [27] . Ceftizoxime does not pass 
the blood-brain barrier, and concentrates more in periph-
eral tissue  [26] . The peak tissue concentrations are ob-
tained 1–3 h after administration  [27] . Ceftizoxime has 
a mean protein binding of 30%  [28] . 
 Ceftizoxime is mostly eliminated via glomerular fi ltra-
tion with a small component of unmodifi ed elimination 
in urine through a tubular secretion mechanism  [27] ; its 
elimination is directly related to renal function and the 
dosage must be reduced in proportion to the decrease in 
creatinine clearance  [29] . 
 In clinical trials, prophylactic ceftizoxime has been 
shown to be able to reduce the incidence of postoperative 
infections just as cefazolin and cefamandole  [30] . 
 The pharmacokinetic characteristics of ceftizoxime 
(high water solubility, low protein binding, high renal 
clearance) could make its serum and tissue concentration 
curve particularly susceptible to fl uid modifi cations. In 
fact, in a clinical trial on 53 patients undergoing emer-
gency explorative laparotomy, Rosemurgy  et al.  [31] 
found that signifi cant blood losses and subsequent abun-
dant fl uid replacement caused serious reductions in anti-
biotic serum concentrations that are signifi cantly related 
to the appearance of postoperative infection. 
 In our study, we attempted to demonstrate that the 
tissue concentrations of ceftizoxime are increased by a 
high fl uid balance. 
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 To evaluate the body compartment distribution of ad-
ministered fl uids, an impedance analyzer was used to 
measure resistance, which expresses conductor opposi-
tion to the fl ow of alternating current, and is inversely 
proportional to total body fl uids, and the capacitive reac-
tance, which expresses condenser opposition to the fl ow 
of alternating current, and is directly proportional to cel-
lular mass. These measurements were useful for assessing 
nutritional status  [10] and dialysis-related modifi cations 
of body fl uid distribution  [11, 12] . 
 The results of this paper demonstrate that in patients 
with higher fl uid balance, in whom we observed reduced 
resistance to fl uid accumulation, antibiotic diffusion and 
tissue concentration were higher. 
 On the basis of these results we hypothesize that if di-
uresis is reduced and the fl uid balance increases during 
an operation, the total body fl uid increases and a high 
fl uid content at the tissue level allows the passage of a 
higher amount of drug in the tissues. 
 The differences observed in diuresis could be related, 
among others, to a relative preoperative dehydratation 
(but the bowel preparation was similar in all the patients) 
as well as to the effect of mechanical ventilation, or intra-
operative minimal variation of kidney perfusion. 
 The passage of a higher amount of drug in the tissues 
is in agreement with the pharmacokinetic characteristics 
of ceftizoxime described above: i.e. highly free (not bound 
to plasma protein) and hydrosoluble drug  [30] . 
 Bioelectrical impedance is essential for the evaluation 
of the effects of fl uid balance and provided signifi cant 
supporting data. In a recent study, bioimpedance analysis 
variations demonstrated a strict correlation with fl uid 
losses during hemodialysis, In that case, the bioimped-
ance analysis variation of 20% was equivalent to a body 
weight decreased by 2.8  8 0.8 kg  [32] . This value is com-
parable with the variation (7% for 1 liter of fl uid balance) 
found in our study. 
 In our series of patients, the time elapsed from the ad-
ministration of drug is not signifi cantly related to the tis-
sue concentration of ceftizoxime. This lacking correlation 
could mean that during a surgical intervention the tissue 
distribution of ceftizoxime is modifi ed by fl uid distribu-
tion more than by peak drug concentration. 
 Further study seems to be necessary to achieve a better 
understanding of the relationship between fl uid adminis-
tration and tissue penetration of antibiotic agents. Knowl-
edge of the mechanisms of tissue diffusion of antimicro-
bial agents could help explain the infrequent but not rare 
failures of surgical infection prophylaxis, particularly in 
colon surgery  [33] . For these reasons as well, the contro-
versy over the choice of antibiotic for surgical prophy-




 1 Classen DC, Scott Evans R, Pestotnik SL, 
Horn SD, Menlove RL, Burke JP: The timing 
of prophylactic administration of antibiotics 
and the risk of surgical wound infection. N 
Engl J Med 1992;  326:  281–285. 
 2 Redington J, Ebert SC, Craig WA: Role of an-
timicrobial pharmacokinetics and pharmaco-
dynamics in surgical prophylaxis. Rev Infect 
Dis 1991;  13(suppl 10):790s–799s. 
 3 Novelli A: Antimicrobial prophylaxis in sur-
gery: The role of pharmacokinetics. J Che-
mother 1999;  11:  565–572. 
 4 Holte K, Sharrock NE, Kehlet H: Pathophysi-
ology and clinical implications of periopera-
tive fl uid excess. Br J Anaesth 2002;  89:  622–
632. 
 5 De Lalla F, Novelli A, Pellizer G, Molocchi F, 
Viola R, Rigon A, Stecca C, Dal Pizzol V, Fal-
lani S, Periti P: Regional and systemic prophy-
laxis with teicoplanin in monolateral and bilat-
eral total knee replacement procedures: Study 
of pharmacokinetics and tissue penetration. 
Antimicrobial Agents Chemother 1993;  37: 
 2693–2697. 
 6 Mazzei T, Tonelli F, Novelli A, et al: Penetra-
tion of cefotetan into suction skin blister fl uid 
and tissue homogenates in patients undergo-
ing abdominal surgery. Antimicrob Agents 
Chemother 1994;  38:  2221–2223. 
 7 Periti P, Rizzo M, Novelli A, Reali EF, Dami 
A, Boni S, Mini E, Mazzei T: Pharmacokinet-
ics and penetration into extravascular fl uid of 
imipenem in patients with normal renal func-
tion; in Berkada B, Kuemmerle HP (eds): 
Progress in Chemotherapy, Antimicrobial Sec-
tion. Munich, Ecomed, 1987, vol 1, pp 990–
992. 
 8 Moretti EW, Robertson KM, El-Moalem H, 
Gan TJ: Intraoperative colloid administra-
tion reduces postoperative nausea and vomit-
ing and improves postoperative outcomes 
compared with crystalloid administration. 
Anesth Analg 2003;  96:  611–617. 
 9 Gan TJ, Soppitt A, Maroof M, el-Moalem H, 
Robertson KM, Moretti E, Dwane P, Glass 
PS: Goal-directed intraoperative fl uid ad-
ministration reduces length of hospital stay 
after major surgery. Anesthesiology 2002;  97: 
 820–826. 
 10 Talluri T, Lietdke RJ, Evangelisti A, Talluri J, 
Maggia G: Fat-free mass qualitative assess-
ment with bioelectric impedance analysis 
(BIA). Ann N Y Acad Sci 1999;  873:  94–98. 
 11 Talluri A, Maggia G: Bioimpedance analysis 
(BIA) in hemodialysis: Technical aspects. Int J 
Artif Organs 1995;  18:  687–692. 
 12 Scanferla F, Landini S, Fracasso A, Morachi-
ello P, Righetto F, Toffoletto PP, Bazzato G: 
On-line bioelectric impedance during haemo-
dialysis: Monitoring of body fl uids and cell 
membrane status. Nephrol Dial Transplant 
1990;  5(suppl 1):167–170. 
 13 Craig W: Pharmacodynamics of antimicrobial 
agents as a basis for determining dosage regi-
mens. Eur J Clin Microbiol Infect Dis 1993; 
 12(suppl 1):6s–8s. 
 14 Novelli GP: Effects of enfl urane and halothane 
on the microcirculation. Acta Anaesthesiol 
Scand Suppl 1979;  71:  64–68. 
 15 Coates DP, Monk CR, Prys-Roberts C, Turtle 
M: Hemodynamic effects of infusions of the 
emulsion formulation of propofol during ni-
trous oxide anesthesia in humans. Anesth 
Analg 1987;  66:  64–70. 
 Di Filippo et al. 
 
 Chemotherapy 2005;51:51–56 56
 16 Banic A, Krejci V, Erni D, Wheatley AM, Si-
gurdsson GH: Effects of sodium nitroprusside 
and phenylephrine on blood fl ow in free mus-
culocutaneous fl aps during general anesthesia 
Anesthesiology 1999;  90:  147–155. 
 17 Tibballs J, Malbezin S: Cardiovascular re-
sponses to induction of anaesthesia with thio-
pentone and suxamethonium in infants and 
children. Anaesth Intensive Care 1988;  16: 
 278–284. 
 18 Ismail EF, Kim SJ, Salem MR, Crystal GJ: Di-
rect effects of propofol on myocardial contrac-
tility in in situ canine hearts. Anesthesiology 
1992;  77:  964–972. 
 19 Matsukawa T, Sessler DI, Sessler AM,
Schroeder M, Ozaki M, Kurz A, Cheng C: Heat 
fl ow and distribution during induction of gen-
eral anesthesia. Anesthesiology 1995;  82:  662–
673. 
 20 Matsukawa T, Kurz A, Sessler DI, Bjorksten 
AR, Merrifi eld B, Cheng C: Propofol linearly 
reduces the vasoconstriction and shivering 
thresholds. Anesthesiology 1995;  82:  1169–
1180. 
 21 Eisele R, Dissmann W, Kotter D, Nasseri M, 
Thimme W: Behavior of the portal vein system 
in man after laparotomy. Surg Gynecol Obstet 
1975;  141:  870–874. 
 22 Kaye AD, Gorgono AW: Fluid and electrolyte 
physiology.  Anesthesia USA 2000;  45:  1587–
1644. 
 23 Gow KW, Phang PT, Tebbutt-Speirs SM, En-
glish JC, Allard MF, Goddard CM, Walley KR: 
Effect of crystalloid administration on oxygen 
extraction in endotoxemic pigs. J Appl Physiol 
1998;  85:  1667–1675. 
 24 Van Bommel J, Siegemund M, Henny CP, 
Trouwborst A, Ince C: Critical hematocrit in 
intestinal tissue oxygenation during severe 
normovolemic hemodilution. Anesthesiology 
2001;  94:  152–160. 
 25 Fasching CE, Peterson LR, Bettin KM,
Gerding DN: High-pressure liquid chromato-
graphic assay of ceftizoxime with an anion-ex-
change extraction technique. Antimicrobial 
Agents Chemother 1982;  22:  336–337. 
 26 Cable D, Edralin G, Overturf GD: Human ce-
rebrospinal fl uid pharmacokinetics and treat-
ment of bacterial meningitis with ceftizoxime. 
J Antimicrobial Chemother 1982;  10:(suppl 
C):121–127. 
 27 Nakayama I, Akieda Y, Tajima K, Kawamura 
H, Kawaguchi H, Nishimoto A, Ishyama S: 
Antimicrobial activity, absorption, excretion, 
metabolism, distribution in tissues and the 
clinical use in surgical infection of a new ceph-
alosporin antibiotic, ceftizoxime. Chemother-
apy (Tokyo) 1980;  28:(suppl 5):495–510. 
 28 Murakawa T, Sakamoto H, Fukada S, Naka-
moto S, Hirose T, Itoh N, Nishida M: Pharma-
cokinetics of ceftizoxime in animals after 
parenteral dosing. Antimicrobial Agents Che-
mother 1982;  21:  925–934. 
 29 Cutler RE, Blair AD, Burgess ED, Parks D: 
Pharmacokinetics of ceftizoxime. J Antimicro-
bial Chem 1982;  10(suppl C):91–97. 
 30 Fainstein V, Weaver S, Bodey GP: In vitro sus-
ceptibilities of  Aeromonas hydrophila against 
new antibiotics. Antimicrobial Agents Che-
mother 1982;  22:  513–514. 
 31 Rosemurgy AS II, Dillon KR, Kurto HA, Al-
brink MH: Ceftizoxime use in trauma celioto-
my: Pharmacokinetics and patient outcomes. 
J Clin Pharmacol 1995;  35:  1046–1051. 
 32 Di Iorio BR, Scalfi  L, Terracciano V, Bellizzi 
V: A systematic evaluation of bioelectrical im-
pedance measurement after hemodialysis ses-
sion. Kidney Int 2004;  65:  2435–2440. 
 33 Rau HG, Mittelkotter U, Zimmermann A, 
Lachmann A, Kohler L, Kullmann KH: Peri-
operative infection prophylaxis and risk factor 
impact in colon surgery. Chemotherapy 2000; 
 46:  353–363. 
 34 Dietrich ES, Bieser U, Frank U, Schwarzer G, 
Daschner FD: Ceftriaxone versus other cepha-
losporins for perioperative antibiotic prophy-
laxis: A meta-analysis of 43 randomized con-
trolled trials. Chemotherapy 2002;  48:  49–56. 
 35 Bratzler DW, Houck PM,   for    the   Surgical   In-
fection   Prevention   Guidelines   Writers   Work-
group   Antimicrobial   Prophylaxis   for   Surgery:  
 An   Advisory   Statement   from   the   National   Sur-
gical   Infection   Prevention   Project.    Clin Infect 
Dis 2004;  38:  1706–1715. 
 
